目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 INCLUSIONS & EXCLUSIONS
1.3.2 MARKETS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.1.1 SECONDARY SOURCES
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY SOURCES
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 INDUSTRY TRENDS
5.4 VALUE CHAIN ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGY
5.5.1.1 NEEDLE-FREE SYSTEMS
5.5.2 COMPLEMENTARY TECHNOLOGY
5.5.2.1 INTEGRATION OF SENSORS IN CLOSED SYSTEM TRANSFER DEVICES
5.5.3 ADJACENT TECHNOLOGY
5.5.3.1 ADVANCEMENTS IN CONTAINMENTS
5.6 PORTER'S FIVE FORCE ANALYSIS
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
5.8 PATENT ANALYSIS
5.9 TRADE ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY DEVICES
5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
5.11 KEY CONFERENCES & EVENTS DURING 2024-2025
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS & BUYING PROCESS
5.13.2 BUYING CRITERIA
5.13 UNMET NEEDS/END USER EXPECTATIONS IN CLOSED SYSTEMS TRANSFER DEVICES MARKET
5.14 ADJACENT MARKET ANALYSIS
5.15 ECOSYSTEM MARKET MAP
5.16 CASE STUDY ANALYSIS
5.17 SUPPLY CHAIN ANALYSIS
5.18 TRENDS/ DISRUPTION IMPACTING CUSTOMER’S BUSINESS
5.19 INVESTMENT AND FUNDING SCENARIO
5.20 AI IN CLOSED TRANSFER SYSTEMS DEVICES
5.21 REIMBURSEMENT SCENARIO

6 CLOSED SYSTEMS TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2021-2029 (USD MILLION)
6.1 INTRODUCTION
6.2 LUER LOCK SYSTEMS
6.3 PUSH TO TURN SYSTEM
6.4 CLICK-TO-LOCK SYSTEM
6.5 COLOUR-TO-COLOUR ALIGNMENT SYSTEMS

7 CLOSED SYSTEMS TRANSFER DEVICES MARKET, BY TYPE, 2021-2029 (USD MILLION)
7.1 INTRODUCTION
7.2 MEMEBRANE-TO-MEMBRANE SYSTEMS
7.3 NEEDLESS SYSTEMS

8 CLOSED SYSTEMS TRANSFER DEVICES MARKET, BY COMPONENT, 2021-2029 (USD MILLION AND VOLUME UNITS*)
8.1 INTRODUCTION
8.2 VAIL ACCESS COMPONENTS
8.3 MALE LUERS
8.4 BAG SPIKES
8.5 FEMALE COMPONENTS
8.6 OTHER COMPONENTS (SYRINGE TRAYS, INFUSION CLAMPS, CAPS, HANGERS FOR INV BAGS, IV BAGS HINGES, INFUSIONS SETS ETC.)
*The volume unit data will be provided at the regional level for North America, Europe, Asia Pacific, Latin America, and Middle East & and Africa

9 CLOSED SYSTEMS TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
9.1 INTRODUCTION
9.2 DIAPHRAGM-BASED DEVICES
9.3 COMPARTMENTALISED DEVICES
9.4 AIR CLEANING/ FILTRATION DEVICES

10 CLOSED SYSTEMS TRANSFER DEVICES MARKET, BY END USER, 2021-2029 (USD MILLION)
10.1 INTRODUCTION
10.2 HOSPITALS AND CLINICS
10.3 ONCOLOGY CENTERS
10.2 OTHER END USERS (ACADEMIC AND RESEARCH INSTITUTES, CLINICAL RESEARCH ORGANISATIONS, AND HOME CARE SETTINGS)

11 CLOSED SYSTEMS TRANSFER DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 RECESSION IMPACT
11.2.2 US
11.2.3 CANADA
11.3 EUROPE
11.3.1 RECESSION IMPACT
11.3.3 GERMANY
11.3.4 UK
11.3.5 FRANCE
11.3.6 SPAIN
11.3.7 ITALY
11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 RECESSION IMPACT
11.4.2 JAPAN
11.4.3 CHINA
11.4.4 INDIA
11.4.5 AUSTRALIA AND NEW ZEALAND
11.4.6 SOUTH KOREA
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 RECESSION IMPACT
11.5.2 BRAZIL
11.5.3 MEXICO
11.5.4 COLOMBIA
11.5.5 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 RECESSION IMPACT
11.6.2 GCC
11.6.3 REST OF MIDDLE EAST AND AFRICA

12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.5 PARTICIPANTS
12.5.6 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.6.1 COMPANY FOOTPRINT
12.5.6.2 REGION FOOTPRINT
12.5.6.3 CLOSING MECHANISM FOOTPRINT
12.5.6.4 TYPE FOOTPRINT
12.5.6.4 COMPONENT FOOTPRINT
12.5.6.5 TECHNOLOGY FOOTPRINT
12.5.6.5 END USER FOOTPRINT
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES
12.6.5.1 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.7 COMPETITIVE SITUATION AND TRENDS
12.7.1 PRODUCT LAUNCHES
12.7.2 DEALS
12.7.3 OTHER DEVELOPMENTS
12.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
12.9 R&D ASSESSMENT OF KEY PLAYERS
12.10 VALUATION AND FINANCIAL METRICS OF KEY PLAYERS IN THE CLOSED SYSTEMS TRANSFER DEVICES MARKET

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 BECTON DICKINSON AND COMAPNY
13.1.2 ICU MEDICAL
13.1.3 EQUASHIELD
13.1.4 B BRAUN MELSUNGEN
13.1.5 JMS
13.1.6 BAXTER INTERNATIONAL
13.1.7 SIMPLIVIA HEALTHCARE
13.1.8 YUYKON MEDICAL
13.1.9 CODAN MEDIZINSCHE GERATE
13.1.10 WEST PHARMACEUTICAL SERVICES
13.1.11 VYGON SA
13.1.12 PRACTIVET
13.1.13 CORNING INCORPORATED
13.1.14 TERUMO INCORPORATED
13.1.15 ELCAM MEDICAL
13.2 START UP/SME PLAYERS
13.2.1 AMNISO INTERNATIONAL, INC.
13.2.2 CARAGEN
13.2.3 CORVIDA
13.2.4 VICTUS
13.2.5 EPIC MEDICAL
13.2.6 ERASER MEDICAL
13.2.7 INSUNG MEDICAL
13.2.8 ADVCARE MEDICAL
13.2.9 EDGE PHARMA
13.2.10 NEEDLESS CORPORATION

14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATION
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS